日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection

西格列汀治疗和抑制人类免疫缺陷病毒感染后减轻炎症和免疫激活的随机、双盲、安慰剂对照试验

Dubé, Michael P; Chan, Ellen S; Lake, Jordan E; Williams, Brett; Kinslow, Jennifer; Landay, Alan; Coombs, Robert W; Floris-Moore, Michelle; Ribaudo, Heather J; Yarasheski, Kevin E

Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed to Rectal Swab Use

利福昔明治疗四周未能显著改变 HIV 感染免疫无应答者直肠样本中的微生物多样性 (ACTG A5286),这可能与使用直肠拭子有关。

Williams, Brett B; Green, Stefan J; Bosch, Ronald J; Chan, Ellen S; Jacobson, Jeffrey M; Margolis, David M; Engen, Phillip; Landay, Alan L; Wilson, Cara C

Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275).

阿托伐他汀对病毒学抑制的人类免疫缺陷病毒-1感染者(低密度脂蛋白胆固醇<130 mg/dL)的免疫激活、炎症和脂质生物标志物的影响(AIDS临床试验组研究A5275)

Nixon Daniel E, Bosch Ronald J, Chan Ellen S, Funderburg Nicholas T, Hodder Sally, Lake Jordan E, Lederman Michael M, Klingman Karin L, Aberg Judith A

Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation

补充维生素D不会影响抗逆转录病毒疗法启动后出现的代谢变化

Muhammad, Josh; Chan, Ellen S; Brown, Todd T; Tebas, Pablo; McComsey, Grace A; Melbourne, Kathleen; Hardin, Royce; Willig, Amanda L; Yin, Michael T; Ribaudo, Heather; Overton, Edgar Turner

Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation.

补充维生素D/钙后,计算出的生物可利用维生素D的种族差异

Yin Michael T, Chan Ellen S, Brown Todd T, Tebas Pablo, McComsey Grace A, Melbourne Kathleen M, Napoli Andrew, Hardin William R, Ribaudo Heather J, Overton Edgar T

Differential CD4+ cell count increase and CD4+ :  CD8+ ratio normalization with maraviroc compared with tenofovir.

与替诺福韦相比,马拉维罗可使 CD4+ 细胞计数差异增加,并使 CD4+:CD8+ 比率正常化

Chan Ellen S, Landay Alan L, Brown Todd T, Ribaudo Heather J, Mirmonsef Paria, Ofotokun Igho, Weitzmann M Neale, Martinson Jeffrey, Klingman Karin L, Eron Joseph J, Fichtenbaum Carl J, Plants Jill, Taiwo Babafemi O

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial

维生素D和钙可减轻抗逆转录病毒治疗初期引起的骨质流失:一项随机试验

Overton, Edgar Turner; Chan, Ellen S; Brown, Todd T; Tebas, Pablo; McComsey, Grace A; Melbourne, Kathleen M; Napoli, Andrew; Hardin, William Royce; Ribaudo, Heather J; Yin, Michael T

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

在艾滋病临床试验组 A5303 研究中,与含替诺福韦的抗逆转录病毒疗法相比,含马拉维罗克的抗逆转录病毒疗法可减少骨质流失

Taiwo, Babafemi O; Chan, Ellen S; Fichtenbaum, Carl J; Ribaudo, Heather; Tsibris, Athe; Klingman, Karin L; Eron, Joseph J; Berzins, Baiba; Robertson, Kevin; Landay, Alan; Ofotokun, Igho; Brown, Todd

Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286

利福昔明对HIV阳性抗逆转录病毒疗法免疫无应答者的微生物移位、T细胞活化和炎症影响甚微 - ACTG A5286

Tenorio, Allan R; Chan, Ellen S; Bosch, Ronald J; Macatangay, Bernard J C; Read, Sarah W; Yesmin, Suria; Taiwo, Babafemi; Margolis, David M; Jacobson, Jeffrey M; Landay, Alan L; Wilson, Cara C

Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission

产时给予奈韦拉平预防母婴传播后血浆奈韦拉平暴露的临床和遗传决定因素

Vardhanabhuti, Saran; Acosta, Edward P; Ribaudo, Heather J; Severe, Patrice; Lalloo, Umesh; Kumarasamy, Nagalingeshwaran; Taulo, Frank; Kabanda, Joseph; Oneko, Olola; Ive, Prudence; Sambarey, Pradeep; Chan, Ellen S; Hitti, Jane; Hong, Francis; McMahon, Deborah; Haas, David W